These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29150389)

  • 1. Galantamine and memantine combination for cognition: Enough or more than enough to translate from murines and macaques to men with schizophrenia?
    Koola MM
    Asian J Psychiatr; 2019 Apr; 42():115-118. PubMed ID: 29150389
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.
    Woodruff-Pak DS; Tobia MJ; Jiao X; Beck KD; Servatius RJ
    Neuropsychopharmacology; 2007 Jun; 32(6):1284-94. PubMed ID: 17119537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia.
    Koola MM; Buchanan RW; Pillai A; Aitchison KJ; Weinberger DR; Aaronson ST; Dickerson FB
    Schizophr Res; 2014 Aug; 157(1-3):84-9. PubMed ID: 24878431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors.
    Nikiforuk A; Potasiewicz A; Kos T; Popik P
    Behav Brain Res; 2016 Oct; 313():214-218. PubMed ID: 27435422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
    Koola MM; Sklar J; Davis W; Nikiforuk A; Meissen JK; Sawant-Basak A; Aaronson ST; Kozak R
    Schizophr Res; 2018 Mar; 193():459-460. PubMed ID: 28705532
    [No Abstract]   [Full Text] [Related]  

  • 6. Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement.
    Koola MM
    Prim Care Companion CNS Disord; 2018 Mar; 20(2):. PubMed ID: 29570959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential.
    Ahnaou A; Huysmans H; Jacobs T; Drinkenburg WH
    Neuropharmacology; 2014 Nov; 86():362-77. PubMed ID: 25181033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease.
    Dengiz AN; Kershaw P
    CNS Spectr; 2004 May; 9(5):377-92. PubMed ID: 15115951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the pharmacology of galantamine.
    Villarroya M; García AG; Marco-Contelles J; López MG
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1987-98. PubMed ID: 18042006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine introduced in Europe.
    Am J Alzheimers Dis Other Demen; 2001; 16(1):8. PubMed ID: 11416951
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin potentiates the therapeutic effect of memantine against central STZ-induced spatial learning and memory deficit.
    Bahramian A; Rastegar K; Namavar MR; Moosavi M
    Behav Brain Res; 2016 Sep; 311():247-254. PubMed ID: 27233828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Effects of Cognitives and Nootropics on Mitochondrial Respiration and Monoamine Oxidase Activity.
    Singh N; Hroudová J; Fišar Z
    Mol Neurobiol; 2017 Oct; 54(8):5894-5904. PubMed ID: 27660276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice.
    Unger C; Svedberg MM; Yu WF; Hedberg MM; Nordberg A
    J Pharmacol Exp Ther; 2006 Apr; 317(1):30-6. PubMed ID: 16354790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacology of galantamine.
    Marco-Contelles J; do Carmo Carreiras M; Rodríguez C; Villarroya M; García AG
    Chem Rev; 2006 Jan; 106(1):116-33. PubMed ID: 16402773
    [No Abstract]   [Full Text] [Related]  

  • 17. Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation.
    Sobrado M; Roda JM; López MG; Egea J; García AG
    Neurosci Lett; 2004 Jul; 365(2):132-6. PubMed ID: 15245794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in electrophysiological markers of cognitive control after administration of galantamine.
    Gascoyne LE; Mullinger KJ; Robson SE; Kumar J; O'Neill GC; Palaniyappan L; Morris PG; Liddle EB; Brookes MJ; Liddle PF
    Neuroimage Clin; 2018; 20():228-235. PubMed ID: 30090697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study.
    Annweiler C; Herrmann FR; Fantino B; Brugg B; Beauchet O
    Cogn Behav Neurol; 2012 Sep; 25(3):121-7. PubMed ID: 22960436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.